14/05/2015
Joint promotion in Korea of the Barcelona Synchrotron Park and the Parc Científic de Barcelona
Joint promotion in Korea of the Barcelona Synchrotron Park and the Parc Científic de Barcelona
Pablo Osuna has been in Seoul for two weeks now for, among other things, the joint promotion of the Barcelona Synchrotron Park (BSP) and the Parc Científic de Barcelona (PCB) to the Korean companies from the healthcare sector.
Pablo Osuna is an ICEX fellow, the Spanish agency for the internationalization of companies. In the coming 12 months, he will work for Pharmaphenix, the company selected to get the benefit of one of the fellows proposed by ICEX every year. Pharmaphenix is a consulting firm from the healthcare sector located at the PCB that helps worldwide companies grow their business. Pharmaphenix maintains special relationship with Korea with a five-person team working in Seoul.
BSP and PCB decided to work together with the support and the know-how of Pharmaphenix in order to jointly promote both parks as privileged locations in Europe for the setting of Korean companies.
Thinking about their internationalization, both parks want to join forces and present the complementarity of their offer in the strong context of the Catalan heathcare sector: on one hand, each park depends on one of the two large Catalan universities in life sciences (Barcelona University-UB for the PCB, Universitat Autonòma de Barcelona-UAB for the BSP) and offers a large science facility in this field (the National Center for Genome Analysis-CNAG at PCB and the ALBA synchrotron at BSP).
On the other hand, both parks have a complementary offer: the PCB proposes office and laboratory spaces and a wide range of scientific services for both small and large companies, especially from the life sciences sector, that want to take advantage of the stimulating environment of the wide park community. For its part, the BSP offers non-built-up plots for large and consolidated companies that look for a propitious environment to R&D and innovation made up of the high density of research centres and companies located around the synchrotron.
Pablo Osuna is an ICEX fellow, the Spanish agency for the internationalization of companies. In the coming 12 months, he will work for Pharmaphenix, the company selected to get the benefit of one of the fellows proposed by ICEX every year. Pharmaphenix is a consulting firm from the healthcare sector located at the PCB that helps worldwide companies grow their business. Pharmaphenix maintains special relationship with Korea with a five-person team working in Seoul.
BSP and PCB decided to work together with the support and the know-how of Pharmaphenix in order to jointly promote both parks as privileged locations in Europe for the setting of Korean companies.
Thinking about their internationalization, both parks want to join forces and present the complementarity of their offer in the strong context of the Catalan heathcare sector: on one hand, each park depends on one of the two large Catalan universities in life sciences (Barcelona University-UB for the PCB, Universitat Autonòma de Barcelona-UAB for the BSP) and offers a large science facility in this field (the National Center for Genome Analysis-CNAG at PCB and the ALBA synchrotron at BSP).
On the other hand, both parks have a complementary offer: the PCB proposes office and laboratory spaces and a wide range of scientific services for both small and large companies, especially from the life sciences sector, that want to take advantage of the stimulating environment of the wide park community. For its part, the BSP offers non-built-up plots for large and consolidated companies that look for a propitious environment to R&D and innovation made up of the high density of research centres and companies located around the synchrotron.
More news
03/08/2016
Pier 01, the new Barcelona technology hub
28/07/2016
Zero 2 Infinity sends satellites into space
22/07/2016
Latest SENER News From Space and the Sun
16/07/2016
Les Dames de Cerdanyola
08/07/2016
The ALBA Synchrotron reveals the inside of hepatitis C-infected cells
30/06/2016
The Bioinformatics Barcelona Initiative
home